Russell Howerton

759 total citations
24 papers, 437 citations indexed

About

Russell Howerton is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Russell Howerton has authored 24 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Surgery and 7 papers in Hepatology. Recurrent topics in Russell Howerton's work include Pancreatic and Hepatic Oncology Research (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Russell Howerton is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Russell Howerton collaborates with scholars based in United States and United Kingdom. Russell Howerton's co-authors include Perry Shen, Clancy J. Clark, Edward A. Levine, Rebecca M. Dodson, Harveshp Mogal, Gregory B. Russell, Fang‐Chi Hsu, Brian W. Loggie, Aaron U. Blackham and A. William Blackstock and has published in prestigious journals such as Gastroenterology, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Russell Howerton

24 papers receiving 431 citations

Peers

Russell Howerton
Hwee Leong Tan Singapore
Myong Hoon Ihn South Korea
Subramanian Nachiappan United Kingdom
W. H. Schreurs Netherlands
Styliani Mantziari Switzerland
Russell Howerton
Citations per year, relative to Russell Howerton Russell Howerton (= 1×) peers Cheng-Chou Lai

Countries citing papers authored by Russell Howerton

Since Specialization
Citations

This map shows the geographic impact of Russell Howerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Howerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Howerton more than expected).

Fields of papers citing papers by Russell Howerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Howerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Howerton. The network helps show where Russell Howerton may publish in the future.

Co-authorship network of co-authors of Russell Howerton

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Howerton. A scholar is included among the top collaborators of Russell Howerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Howerton. Russell Howerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mangieri, Christopher W., Cristian D. Valenzuela, Ian Solsky, et al.. (2023). Comparison of survival for metastatic pancreatic cancer patients treated with CPI‐613 versus resected borderline‐resectable pancreatic cancer patients. Journal of Surgical Oncology. 128(5). 844–850. 3 indexed citations
2.
Mangieri, Christopher W., Omeed Moaven, Cristian D. Valenzuela, et al.. (2023). Risk factors and outcomes for cholangitis after hepatic resection. Langenbeck s Archives of Surgery. 408(1). 236–236. 1 indexed citations
3.
Mangieri, Christopher W., Cristian D. Valenzuela, Richard A. Erali, et al.. (2022). Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy: Focus on Hepatic Recurrence. Annals of Surgical Oncology. 29(5). 3219–3228. 7 indexed citations
4.
Mangieri, Christopher W., Cristian D. Valenzuela, Richard A. Erali, et al.. (2022). ASO Visual Abstract: Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy—Focus on Hepatic Recurrence. Annals of Surgical Oncology. 29(5). 3231–3231. 1 indexed citations
5.
Mangieri, Christopher W., Cristian D. Valenzuela, Richard A. Erali, et al.. (2021). High-risk liver patients are not associated with adverse events following pancreaticoduodenectomy. HPB. 23. S517–S517. 1 indexed citations
6.
Moaven, Omeed, Georgina Russell, Christopher W. Mangieri, et al.. (2020). Treatment patterns and outcomes in resected pancreatic cancers: Frequent deviations from standard of care. HPB. 22. S91–S92. 1 indexed citations
7.
Chouliaras, Konstantinos, Greg Russell, Edward A. Levine, et al.. (2020). Hepatic arterial infusion chemotherapy for colorectal liver metastases revisited. HPB. 22(9). 1265–1270. 1 indexed citations
8.
Moaven, Omeed, Clancy J. Clark, Gregory B. Russell, et al.. (2020). Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer. Annals of Surgery. 274(6). 1058–1066. 8 indexed citations
9.
Enomoto, Laura M., Rodwige J. Desnoyers, Boris Pasche, et al.. (2019). Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy. Annals of Surgical Oncology. 26(5). 1512–1518. 17 indexed citations
10.
Mogal, Harveshp, Rebecca M. Dodson, Fang‐Chi Hsu, et al.. (2017). Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy. Annals of Surgical Oncology. 24(6). 1714–1721. 116 indexed citations
11.
Shen, Perry, Aaron U. Blackham, Clancy J. Clark, et al.. (2017). Phase II Randomized Trial of Negative-Pressure Wound Therapy to Decrease Surgical Site Infection in Patients Undergoing Laparotomy for Gastrointestinal, Pancreatic, and Peritoneal Surface Malignancies. Journal of the American College of Surgeons. 224(4). 726–737. 77 indexed citations
12.
Ihemelandu, Chukwuemeka, Edward A. Levine, Mebea Aklilu, et al.. (2013). Optimal Timing of Systemic Therapy in Resectable Colorectal Liver Metastases. The American Surgeon. 79(4). 414–421. 7 indexed citations
13.
Shores, Nathan J., Adolfo Fernandez, Kim R. Geisinger, et al.. (2010). S1849 Hepatic Acyl-CoA:Cholesterol O-Acyltransferase 2 (Acat2) Activity Predicts Hepatic Steatosis in Humans. Gastroenterology. 138(5). S–802. 1 indexed citations
14.
Shen, Perry, John H. Stewart, Russell Howerton, et al.. (2008). Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected Patients. Annals of Surgical Oncology. 15(12). 3422–3432. 57 indexed citations
15.
Mishra, Girish, Yiwen Zhao, John Sweeney, et al.. (2006). Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointestinal Endoscopy. 63(4). 648–654. 33 indexed citations
16.
Mishra, Girish, J.M. Butler, Coty Ho, et al.. (2005). Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 28(4). 345–350. 34 indexed citations
17.
Trupiano, Jacqueline K., et al.. (2004). Oncocytic Biliary Cystadenocarcinoma: A Case Report and Review of the Literature. Archives of Pathology & Laboratory Medicine. 128(2). e25–e28. 9 indexed citations
18.
Hawksworth, Jason, Kim R. Geisinger, Ronald J. Zagoria, et al.. (2004). Surgical and Ablative Treatment for Metastatic Adenocarcinoma to the Liver from Unknown Primary Tumor. The American Surgeon. 70(6). 512–517. 13 indexed citations
19.
Howerton, Russell, et al.. (1996). Double Hormone Syndromes in Two Pancreatic Neuroendocrine Tumours. HPB Surgery. 9(4). 261–263. 4 indexed citations
20.
Howerton, Russell, Michael T. Watkins, & Leonid Feldman. (1991). Late arterial hemorrhage secondary to a Greenfield filter requiring operative intervention.. PubMed. 109(3 Pt 1). 265–8. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026